Inhibition of dengue NS2B-NS3 protease and viral replication in Vero cells by recombinant retrocyclin-1

BMC Infectious Diseases

Volumn 12, Issue , 2012, Pages

  Rothan, Hussin A ^a   Han, Heh Choon ^a   Ramasamy, Thamil Selvee ^a   Othman, Shatrah ^a   Rahman, Noorsaadah Abd ^a   Yusof, Rohana ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

Dengue virus; NS2B NS3 protease; Protease activity; Recombinant peptides; Retrocyclin 1; Viral inhibition

Indexed keywords

DEFENSIN; DISULFIDE; NICKEL; RETROCYCLIN 1; SERINE PROTEINASE; UNCLASSIFIED DRUG; VIRUS RNA;

AFFINITY CHROMATOGRAPHY; ALKALINITY; ANIMAL CELL; ANTIVIRAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DENGUE; DILUTION; DISULFIDE BOND; ENZYME ACTIVITY; ENZYME ASSAY; ENZYME INHIBITION; ENZYME PURIFICATION; ENZYME SYNTHESIS; ESCHERICHIA COLI; IC 50; NONHUMAN; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SEROTYPE; SPECTROFLUOROMETRY; TEMPERATURE DEPENDENCE; VERO CELL; VIRUS REPLICATION;

ANIMALS; CERCOPITHECUS AETHIOPS; DEFENSINS; DENGUE VIRUS; ENDOPEPTIDASES; RECOMBINANT PROTEINS; VERO CELLS; VIRAL PROTEINS; VIRUS REPLICATION;

EID: 84869218137     PISSN: None     EISSN: 14712334     Source Type: Journal    
DOI: 10.1186/1471-2334-12-314     Document Type: Article

References (34)

1. Anonymous Division of vector-borne infectious disease. Dengue fever fact sheet 2005, Centres for Disease Control & Prevention, Available at: http://www.cdc.gov/ncidod/dvbid/dengueS, Anonymous.
2. Stadler K, Allison SL, Schalich J, Heinz FX. Proteolytic activation of tick-borne encephalitis virus by furin. J Virol 1997, 71:8475-8481. 192310, 9343204.
3. Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression and replication. Annu Rev Microbiol 1990, 44:649-688. 10.1146/annurev.mi.44.100190.003245, 2174669.
4. Falgout B, Pethel M, Zhang YM, Lai CJ. Both non-structural proteins NS2B and NS3 are required for the proteolytic processing of dengue virus nonstructural proteins. J Virol 1991, 65:2467-2475. 240601, 2016768.
5. Yusof R, Clum S, Wetzel M, Murthy HM, Padmanabhan R. Purified NS2B/NS3 serine protease of dengue virus type 2 exhibits cofactor NS2B dependence for cleavage of substrates with dibasic amino acids in vitro. J Biol Chem 2000, 275:9963-9969. 10.1074/jbc.275.14.9963, 10744671.
6. Lin C, Amberg SM, Chambers TJ, Rice CM. Cleavage at the novel site in the NS4A region by the yellow fever virus NS2B-3proteinase is a prerequisite for processing at the downstream 4A/4B signalase site. J Virol 1993, 67:2327-2335. 240389, 8445732.
7. Arias CF, Preugschat F, Strauss JH. Dengue 2 virus NS2B and NS3 form a stable complex that can cleave NS3 within the helicase domain. Virology 1993, 193:888-899. 10.1006/viro.1993.1198, 8460492.
8. Lobigs M. Flavivirus premembrane protein cleavage and spike heterodimer secretion require the function of the viral proteinase NS3. Proc Natl Acad Sci U S A 1993, 90:6218-6222. 10.1073/pnas.90.13.6218, 46899, 8392191.
9. Clum S, Ebner KE, Padmanabhan R. Cotranslational membrane insertion of the serine proteinase precursor NS2B-NS3 (Pro) of dengue virus type 2 is required for efficient in vitro processing and is mediated through the hydrophobic regions of NS2B. J Biol Chem 1997, 272:30715-30723. 10.1074/jbc.272.49.30715, 9388208.
10. Teo KF, Wright PJ. Internal proteolysis of the NS3 protein specified by dengue virus 2. J Gen Microbiol 1997, 78:337-341.
11. Stocks CE, Lobigs M. Signal peptidase cleavage at the flavivirus C-prM junction: dependence on the viral NS2B-3 protease for efficient processing requires determinants in C, the signal peptide, and prM. J Virol 1998, 72:2141-2149. 109509, 9499070.
12. Geiss BJ, Stahla H, Hannah AM, Gari AM, Keenan SM. Focus on flaviviruses: current and future drug targets. Future. Med Chem 2009, 1:327-344.
13. Tomlinson SM, Malmstrom RD, Watowich SJ. New approaches to structure-based discovery of dengue protease inhibitors. Infect Disorders- Drug Targets 2009, 9:327-343.
14. Murrell S, Wu S, Butler M. Review of dengue virus and the development of a vaccine. Biotechnol Adv 2011, 29:239-247. 10.1016/j.biotechadv.2010.11.008, 21146601.
15. Tambunan US, Alamudi S. Designing cyclic peptide inhibitor of dengue virus NS3-NS2B protease by using molecular docking approach. Bioinformation 2010, 5:250-254. 10.6026/97320630005250, 3055701, 21364826.
16. Tambunan US, Apriyanti N, Parikesit AA, Chua W, Wuryani K. Computational design of disulfide cyclic peptide as potential inhibitor of complex NS2B-NS3 dengue virus Protease. African J Biotechnol. 2011, 10:12281-12290.
17. Daly NL, Chen YK, Rosengren KJ, Marx UC, Phillips ML, Waring AJ, Wang W, Lehrer RI, Craik DJ. Retrocyclin-2: structural analysis of a potent anti-HIV theta-defensin. Biochemistry 2007, 46:9920-9928. 10.1021/bi700720e, 17685559.
18. Münk C, Wei G, Yang OO, Waring AJ, Wang W, Hong T, Lehrer RI, Landau NR, Cole AM. The theta-defensin, retrocyclin, inhibits HIV-1 entry. AIDS Res Hum Retroviruses 2003, 19:875-881. 10.1089/088922203322493049, 14585219.
19. Tang YQ, Yuan J, Osapay G, Ösapay K, Tran D, Miller CJ, Ouellette AJ, Selsted ME. A cyclic antimicrobial peptide produced in primate leukocytes by the ligation of two truncated α-Defensins. Science 1999, 286:498-502. 10.1126/science.286.5439.498, 10521339.
20. Penberthy WT, Chari S, Cole AL, Cole AM. Retrocyclins and their activity against HIV-1. Cell Mol Life Sci 2011, 68:2231-2242. 10.1007/s00018-011-0715-5, 21553001.
21. Venkataraman N, Cole AL, Ruchala P, Waring AJ, Lehrer RI. Reawakening Retrocyclins: Ancestral Human Defensins Active Against HIV-1. PLoS Biol 2009, 7:e1000095.
22. Sijwali PS, Brinen L, Rosenthal PJ. Systematic optimization of expression and refolding of the Plasmodium falciparum cysteine protease falcipain-2. Protein Expression Purif. 2001, 22:128-134.
23. Rothan HA, Abdulrahman AY, Sasikumer PG, Othman S, Abd Rahman N, Yusof R. Protegrin-1 Inhibits Dengue NS2B-NS3 Serine Protease and Viral Replication in MK2 Cells. J Biomed Biotechnol 2012, ID 251482.
24. Cheng Y, Prusoff WH. Relationship between the inhibition constant (Ki) and the concentration of inhibitor which causes 50 per cent inhibition (IC50) of an enzymatic reaction. Biochemistry Pharmacol. 1973, 22:3099-3108.
25. Lamers RP, Eade CR, Waring AJ, Cole AL, Cole AM. Characterization of the Retrocyclin Analogue RC-101 as a Preventative of Staphylococcus aureus Nasal ColonizationAntimicrob. Antimicrob Agents Chemother 2011, 55:5338-5346. 10.1128/AAC.00619-11, 3195007, 21825301.
26. Cole AM, Cole AL. Antimicrobial polypeptides are key Anti-HIV-1 effector molecules of cervicovaginal host defense. Am J Reproduction Immunol. 2008, 59:27-34.
27. Steuer C, Heinonen KH, Kattner L, Klein CD. Optimization of assayconditions for dengue virus protease: effect of various polyols and non-ionic detergents. J Bimolecular Screening 2009, 14:1102-1108.
28. Erbel P, Schiering N, D'Arcy A, Renatus M, Kroemer M, Lim S, Yin Z, Keller T, Vasudevan G, Hommel U. Structural basis for the activation of flaviviral NS3 proteases from dengue and West Nile virus. Nat Struct Mol Biol 2006, 13:372-373. 10.1038/nsmb1073, 16532006.
29. Owen SM, Rudolph DL, Wang W, Cole AM, Waring AJ, Lal RB, Lehrer RI. RC-101, a retrocyclin-1 analogue with enhanced activity against primary HIV type 1 isolates. AIDS Res Hum Retroviruses 2004, 20:1157-1165. 10.1089/aid.2004.20.1157, 15588337.
30. Liang Q, Zhou K, He H. Retrocyclin 2: a new therapy against avian influenza H5N1 virus in vivo and vitro. Biotechnology Letter 2009, 32:387-392.
31. Yasin B, Wang W, Pang M, Cheshenko N, Hong T, Waring AJ, Herold BC, Wagar EA, Lehrer RI. θ defensins protect cells from infection by herpes simplex virus by inhibiting viral adhesion and entry. J Virology 2004, 78:5147-5156. 10.1128/JVI.78.10.5147-5156.2004, 400355, 15113897.
32. Wang W, Mulakala C, Ward SC, Jung G, Luong H, Pham D, Waring AJ, Kaznessis Y, Lu W, Bradley KA, Lehrer RI. Retrocyclins kill bacilli and germinating spores of bacillus anthracis and inactivate anthrax lethal toxin. J Biol Chem 2006, 281:32755-32764. 10.1074/jbc.M603614200, 2440672, 16790431.
33. Lee SB, Li B, Jin S, Daniell H. Expression and characterization of antimicrobial peptides Retrocyclin-101 and Protegrin-1 in chloroplasts to control viral and bacterial infections Plant. Biotechnol J 2011, 9:100-115.
34. Yang CC, Hsieh YC, Lee SJ, Wu SH, Liao CL, Tsao CH, Chao YS, Chern JH, Wu CP, Yueh A. Novel dengue virus-specific NS2B/NS3 Protease Inhibitor, BP2109, discovered by a high-throughput screening assay. Antimicrob Agents Chemother 2011, 55:229-238. 10.1128/AAC.00855-10, 3019636, 20937790.